KR890004680A - 좌 약 - Google Patents

좌 약 Download PDF

Info

Publication number
KR890004680A
KR890004680A KR1019880011875A KR880011875A KR890004680A KR 890004680 A KR890004680 A KR 890004680A KR 1019880011875 A KR1019880011875 A KR 1019880011875A KR 880011875 A KR880011875 A KR 880011875A KR 890004680 A KR890004680 A KR 890004680A
Authority
KR
South Korea
Prior art keywords
suppository
calcitonin
acid
weight
salt
Prior art date
Application number
KR1019880011875A
Other languages
English (en)
Other versions
KR970003052B1 (ko
Inventor
아즈리아 모이제
미켈스타이거
Original Assignee
예안 크라메르 한스 루돌프 하우스
산도즈 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878721700A external-priority patent/GB8721700D0/en
Priority claimed from GB888801991A external-priority patent/GB8801991D0/en
Priority claimed from GB888805068A external-priority patent/GB8805068D0/en
Application filed by 예안 크라메르 한스 루돌프 하우스, 산도즈 리미티드 filed Critical 예안 크라메르 한스 루돌프 하우스
Publication of KR890004680A publication Critical patent/KR890004680A/ko
Application granted granted Critical
Publication of KR970003052B1 publication Critical patent/KR970003052B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)

Abstract

내용없음.

Description

좌약
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (9)

  1. 좌약기제, 칼시토닌, 및 타우로콜레인산 또는 이것의 약화적 허용염을 포함하는 좌약.
  2. 제1항에 있어서, 상기 타우로콜레인산이 나트륨염의 형태로 존재하는 좌약.
  3. 제1항에 있어서, 상기 타우로콜레인산 또는 그 염이 좌약의 1.8내지 4중량%포함되는 좌약.
  4. 제1항에 있어서, 상기 칼시토닌이 유리염기형태, 약학적 허용산부가염 형태 또는 착염형태의 인체, 연어 또는 뱀장어 칼시토닌인 좌약.
  5. 제1항에 있어서, pH 가 3.8내지 5.0이 되도록 완충제를 함유하는 좌약.
  6. 제1항에 있어서, 부가의 수용성 부형제를 함유하는 좌약.
  7. 제6항에 있어서, 상기 수용성부형제가 만니톨 또는 락토오스인 좌약.
  8. 제6항에 있어서, 좌약의 중량에 대하여 1 내지 10중량%의 수용성부형제를 함유하는 좌약.
  9. 제1항에 있어서, 50,100,200또는 300I.U의 연어 칼시토닌을 함유하는 좌약.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880011875A 1987-09-15 1988-09-14 좌약 KR970003052B1 (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB8721700 1987-09-15
GB878721700A GB8721700D0 (en) 1987-09-15 1987-09-15 Organic compounds
GB8801991 1988-01-29
GB888801991A GB8801991D0 (en) 1988-01-29 1988-01-29 Improvements in/relating to organic compounds
GB8805068 1988-03-03
GB888805068A GB8805068D0 (en) 1988-03-03 1988-03-03 Improvements in/relating to organic compounds

Publications (2)

Publication Number Publication Date
KR890004680A true KR890004680A (ko) 1989-05-09
KR970003052B1 KR970003052B1 (ko) 1997-03-14

Family

ID=27263605

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880011875A KR970003052B1 (ko) 1987-09-15 1988-09-14 좌약

Country Status (26)

Country Link
US (1) US5149537A (ko)
JP (1) JPH01228919A (ko)
KR (1) KR970003052B1 (ko)
AT (1) AT396424B (ko)
AU (1) AU614769B2 (ko)
BE (1) BE1001937A3 (ko)
CA (1) CA1330417C (ko)
CH (1) CH677320A5 (ko)
CY (1) CY1763A (ko)
DE (1) DE3830245A1 (ko)
DK (1) DK509888A (ko)
ES (1) ES2012119A6 (ko)
FI (1) FI87889C (ko)
FR (1) FR2620331B1 (ko)
GB (1) GB2209670B (ko)
HK (1) HK19394A (ko)
HU (1) HU203204B (ko)
IL (1) IL87747A (ko)
LU (1) LU87334A1 (ko)
MY (1) MY103611A (ko)
NL (1) NL8802274A (ko)
NO (1) NO175518C (ko)
NZ (1) NZ226162A (ko)
PH (1) PH24766A (ko)
PT (1) PT88491B (ko)
SE (1) SE8803222L (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170003002A (ko) * 2015-06-30 2017-01-09 (주)아모레퍼시픽 화장료 조성물

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0520983A4 (en) * 1990-03-15 1993-04-28 Rhone-Poulenc Rorer International (Holdings) Inc. Calcitonin suppository formulations
GB9013448D0 (en) * 1990-06-15 1990-08-08 Sandoz Ltd Pharmaceutical resorption-improved somatostatin compositions,their preparation and use
DE4222647A1 (de) * 1991-07-15 1993-01-21 Sandoz Ag Peptid-zubereitungen
US5262172A (en) * 1992-06-19 1993-11-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing buffered bile acids
JPH0776527A (ja) * 1993-06-28 1995-03-20 Hayashibara Biochem Lab Inc 半固形製剤とその製造方法
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
US7303768B2 (en) * 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
US6251428B1 (en) 1998-07-24 2001-06-26 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US20050158408A1 (en) * 1998-07-24 2005-07-21 Yoo Seo H. Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
KR100848344B1 (ko) * 2000-02-04 2008-07-25 유서홍 담즙산 함유 청정 수용액 제형의 제조
US7145125B2 (en) 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
CN1856321B (zh) 2003-07-23 2012-10-03 诺瓦提斯公司 降钙素在骨关节炎中的用途
DE602005019582D1 (de) * 2004-08-30 2010-04-08 Seo Hong Yoo Nervenschutzwirkung von aufgelöster udca bei einem fokalen ischämischen modell
CA2584184A1 (en) * 2004-10-15 2006-04-27 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
DE602005025391D1 (de) * 2004-11-01 2011-01-27 Seo Hong Yoo Verfahren und zusammensetzungen zur verringerung der neurodegeneration bei amyotrophischer lateralsklerose
US8143314B1 (en) 2007-09-13 2012-03-27 Robert Carl Stover Methods and formulations for treating ineffective or decreased esophageal motility

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH211204A (de) * 1938-12-13 1940-08-31 Chem Ind Basel Verfahren zur Herstellung einer Suppositoriengrundmasse.
US4164573A (en) * 1975-06-13 1979-08-14 Galinsky Alvin M Composition and method for making a suppository for introducing a hypoglycemic agent into a mammal
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
DE3068743D1 (en) * 1980-01-16 1984-08-30 Weder Hans G Process and dialysis-installation for the preparation of bilayer-vesicles and their use
JPS56118013A (en) * 1980-02-25 1981-09-16 Teijin Ltd Calcitonin pharmaceutical and its preparation
JPS56138110A (en) * 1980-03-28 1981-10-28 Teijin Ltd Suppository containing citric acid or salt thereof
JPS56138115A (en) * 1980-03-31 1981-10-28 Teijin Ltd Suppository containing acidic amino acid or derivative thereof
EP0037943B1 (en) * 1980-03-31 1985-08-14 Teijin Limited Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom
IL64397A0 (en) * 1981-01-07 1982-02-28 Weder Hans G Process for the preparation of liposomal medicaments
AU572815B2 (en) * 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application
US4801577A (en) * 1987-02-05 1989-01-31 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
IT1222734B (it) * 1987-09-25 1990-09-12 Scalvo S P A Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170003002A (ko) * 2015-06-30 2017-01-09 (주)아모레퍼시픽 화장료 조성물

Also Published As

Publication number Publication date
CH677320A5 (ko) 1991-05-15
JPH01228919A (ja) 1989-09-12
HUT47864A (en) 1989-04-28
AU614769B2 (en) 1991-09-12
AT396424B (de) 1993-09-27
BE1001937A3 (fr) 1990-04-17
NO175518C (no) 1994-10-26
KR970003052B1 (ko) 1997-03-14
CY1763A (en) 1994-07-15
DK509888A (da) 1989-03-16
DE3830245A1 (de) 1989-03-30
PT88491B (pt) 1992-11-30
AU2217588A (en) 1989-04-20
CA1330417C (en) 1994-06-28
NZ226162A (en) 1991-03-26
IL87747A0 (en) 1989-02-28
FR2620331B1 (fr) 1991-11-08
LU87334A1 (fr) 1989-07-07
ATA224788A (de) 1993-01-15
NL8802274A (nl) 1989-04-03
IL87747A (en) 1992-05-25
SE8803222D0 (sv) 1988-09-13
NO884053D0 (no) 1988-09-13
HU203204B (en) 1991-06-28
GB8821429D0 (en) 1988-10-12
NO884053L (no) 1989-03-16
FI87889B (fi) 1992-11-30
NO175518B (no) 1994-07-18
ES2012119A6 (es) 1990-03-01
PT88491A (pt) 1988-10-01
US5149537A (en) 1992-09-22
PH24766A (en) 1990-10-01
MY103611A (en) 1993-08-28
DK509888D0 (da) 1988-09-13
FI87889C (fi) 1993-03-10
GB2209670B (en) 1991-05-08
HK19394A (en) 1994-03-18
GB2209670A (en) 1989-05-24
FI884191A0 (fi) 1988-09-13
FR2620331A1 (fr) 1989-03-17
FI884191A (fi) 1989-03-16
SE8803222L (sv) 1989-03-16

Similar Documents

Publication Publication Date Title
KR890004680A (ko) 좌 약
SE8103419L (sv) Anordning vid betongblock
KR850007208A (ko) 약산성욕 염조성물
SE8700137D0 (sv) Diuretisk komposition
KR840005659A (ko) 연무치약
KR890006644A (ko) 결정성 β-락탐 수화물
KR840005076A (ko) A-21978c 사이클릭펩티드 유도체의 제조방법
KR880008808A (ko) 비경구투여용 현탁액
RU95119203A (ru) Иммуномодулирующее средство
KR880008799A (ko) 욕제조성물
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
ES2056848T3 (es) Copolimeros hidrosolubles, un procedimiento para su obtencion y su empleo.
KR850008278A (ko) 니카르디핀 염산염의 주사용 제제의 제조방법
KR840002901A (ko) 세라펩타제를 안정화 세라펩타제를 안정화 시키는 방법
KR830005360A (ko) 키자니마이신의 제조방법
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
DE68903597D1 (de) Weichkapselzubereitung von natriumpicosulfat.
SE8206728D0 (sv) Lekemedelspreparat
FR2385793A1 (fr) Composition de shampooing acide
KR910007540A (ko) 혈구 감소 장해의 예방ㆍ치료제
KR940011006A (ko) 황금추출물을 유효성분으로 하는 치주질환예방 및 치료제 조성물
KR930013086A (ko) 난백을 이용한 효모 엑스(extract)의 제조방법
郑伯承 ZHANG ZHONGJING, THE SAGE OF CHINESE MEDICINE
KR850007455A (ko) 납(로우)모형용왁스 혼합물
KR890000647A (ko) 무좀 방지용 비누의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
NORF Unpaid initial registration fee